Levobupivakain Kabi

Levobupivacaine Hydrochloride, the active ingredient in Levobupivakain Kabi, is a local anesthetic (amide) presented as a sterile solution for epidural, infiltration, intrathecal and peripheral administration. It provides reversible nerve block for surgical anesthesia, labor analgesia and postoperative pain management. GNH USA supplies Levobupivakain Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivakain Kabi, a local anesthetic, provides nerve block for various surgical and obstetric procedures.

Surgical anesthesia: delivers dense sensory block to facilitate operative procedures. Labor analgesia: offers effective pain relief during childbirth. Postoperative pain management: reduces pain intensity after surgery.

Adverse reactions may occur following administration of Levobupivakain Kabi.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Nausea: feeling of sickness. - Dizziness: light‑headed sensation. - Metallic taste: transient taste alteration. - Injection site pain: discomfort at the injection site.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm. - Seizures: uncontrolled electrical activity in the brain. - Methemoglobinemia: abnormal hemoglobin levels. - Allergic reactions: rash, itching, or anaphylaxis. - Central nervous system toxicity: confusion or loss of consciousness. - Persistent nerve block: prolonged loss of sensation.

When using Levobupivakain Kabi, consider the following safety measures.

Patient assessment: evaluate cardiovascular and hepatic status before administration. Dose adjustment in hepatic impairment: reduce dose if liver function is compromised. Avoid in known hypersensitivity: do not administer to patients with documented allergy to amide local anesthetics. Monitor cardiovascular status: observe blood pressure and heart rate during and after injection. Use with caution in pregnancy: safety data are limited; weigh benefits against potential risks. Store at room temperature: keep in original container, protect from moisture and light.

Levobupivakain Kabi may interact with other medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other local anesthetics: increased risk of cumulative toxicity. - CYP3A4 inhibitors: may raise plasma concentrations of levobupivacaine. - Class I antiarrhythmics: can enhance cardiotoxic effects.

Moderate Interactions (Monitor Closely): - Epinephrine: may prolong block duration. - Diuretics: can alter protein binding and free drug levels. - Beta‑blockers: may mask tachycardia signs of toxicity.